Along these lines, advanced glycation end products (AGEs), resulting from non-enzymatic glycation of plasma proteins during hyperglycemia and thus increased in T2DM patients [171], have been shown to upregulate NLRP3 expression [172]. Here, NLRP3 is linked to Hyperglycemia.